Matches in Wikidata for { <http://www.wikidata.org/entity/Q37471694> ?p ?o ?g. }
- Q37471694 description "article científic" @default.
- Q37471694 description "article scientifique" @default.
- Q37471694 description "articolo scientifico" @default.
- Q37471694 description "artigo científico" @default.
- Q37471694 description "artículu científicu espublizáu en 2013" @default.
- Q37471694 description "bilimsel makale" @default.
- Q37471694 description "scientific article published on 19 December 2013" @default.
- Q37471694 description "vedecký článok" @default.
- Q37471694 description "vetenskaplig artikel" @default.
- Q37471694 description "videnskabelig artikel" @default.
- Q37471694 description "vědecký článek" @default.
- Q37471694 description "wetenschappelijk artikel" @default.
- Q37471694 description "wissenschaftlicher Artikel" @default.
- Q37471694 description "наукова стаття, опублікована в грудні 2013" @default.
- Q37471694 description "научни чланак" @default.
- Q37471694 description "مقالة علمية نشرت في 19 ديسمبر 2013" @default.
- Q37471694 name "Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry" @default.
- Q37471694 name "Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry" @default.
- Q37471694 name "Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry" @default.
- Q37471694 type Item @default.
- Q37471694 label "Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry" @default.
- Q37471694 label "Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry" @default.
- Q37471694 label "Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry" @default.
- Q37471694 prefLabel "Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry" @default.
- Q37471694 prefLabel "Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry" @default.
- Q37471694 prefLabel "Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry" @default.
- Q37471694 P1433 Q37471694-002AD44F-EC9C-41D9-9528-922F3DA47F86 @default.
- Q37471694 P1476 Q37471694-938C9041-940A-4A95-8CEC-E5C9F4649776 @default.
- Q37471694 P2093 Q37471694-0C2594FD-3A64-43A3-8F2B-09BE8E9FA67D @default.
- Q37471694 P2093 Q37471694-34F4109C-EB97-46A4-885C-DEA253782DA8 @default.
- Q37471694 P2093 Q37471694-39A11E70-FBFC-40E2-ADAA-23D453D96DD2 @default.
- Q37471694 P2093 Q37471694-4E04DDA2-7F95-485A-BE70-49953F366390 @default.
- Q37471694 P2093 Q37471694-60CA5C6D-DC30-40A6-8A24-7D7BDFF4FAB1 @default.
- Q37471694 P2093 Q37471694-A5335CEB-0C4A-4969-86AE-74B11E0F70F9 @default.
- Q37471694 P2093 Q37471694-B79A125E-4D79-4A71-912B-4DA92A50AC8F @default.
- Q37471694 P2093 Q37471694-B7B8390E-3476-4E0D-8A87-0AB525652D4C @default.
- Q37471694 P2093 Q37471694-BBA11994-EC70-460A-B66E-1DCACF4A24AC @default.
- Q37471694 P2093 Q37471694-E10A29FE-8FA8-4380-9229-6D8F37B22D64 @default.
- Q37471694 P2093 Q37471694-FD4E3AFC-49B0-462B-B64A-0ECAD88E4CE4 @default.
- Q37471694 P2507 Q37471694-6779BD06-50DC-470F-8E86-2CB012939028 @default.
- Q37471694 P275 Q37471694-3551dc53-7a80-4372-beb5-53dea571f614 @default.
- Q37471694 P2860 Q37471694-023ADCD6-9BFC-49F4-821E-00F9F7A693F8 @default.
- Q37471694 P2860 Q37471694-03FA46D9-6978-468A-A4D2-ADF9D9D0BC07 @default.
- Q37471694 P2860 Q37471694-150B11F7-6921-40E9-8709-FD7998562971 @default.
- Q37471694 P2860 Q37471694-171D4EAA-F9E4-4067-B9E8-CD12B67451AF @default.
- Q37471694 P2860 Q37471694-343A93EA-3528-4437-81A3-FA1394DE0983 @default.
- Q37471694 P2860 Q37471694-35C3C1FF-09F9-4A1C-85FA-5C8A26BBD46B @default.
- Q37471694 P2860 Q37471694-3A86F4D2-A659-4FF1-B32C-4764D9F0B2A1 @default.
- Q37471694 P2860 Q37471694-4C98270F-FD81-4199-BDEE-D39140CDAB36 @default.
- Q37471694 P2860 Q37471694-5228E2E9-2534-44FF-8E74-492D1967FB38 @default.
- Q37471694 P2860 Q37471694-529BDE0E-FC96-4EC2-8676-774873415241 @default.
- Q37471694 P2860 Q37471694-65E85935-3324-4982-8C62-A4BF977B98A9 @default.
- Q37471694 P2860 Q37471694-7F1F9129-7521-4CBE-BFD5-68316E9289F8 @default.
- Q37471694 P2860 Q37471694-7FA4F16E-7782-491A-BE36-7F10B23EDF8D @default.
- Q37471694 P2860 Q37471694-85345202-92EF-432F-B296-86EA559FBCD1 @default.
- Q37471694 P2860 Q37471694-BD3C5430-7F5D-4F0F-960D-9F8CB78E0814 @default.
- Q37471694 P2860 Q37471694-C0FDADA9-80E1-4D27-8AD4-78A9583EA844 @default.
- Q37471694 P2860 Q37471694-C73F72BB-7B47-4009-ACC2-A66D608ECEB2 @default.
- Q37471694 P2860 Q37471694-D3FE22D0-8605-4630-94F0-91B3EAAD6BE6 @default.
- Q37471694 P2860 Q37471694-E46DC5B9-CE6B-456E-B355-97F4AAE98FB3 @default.
- Q37471694 P2860 Q37471694-ED0DCAF2-7C1E-4E54-8764-5FC039E0133B @default.
- Q37471694 P2888 Q37471694-65325A12-B385-4888-8EE0-C80903D1F02D @default.
- Q37471694 P304 Q37471694-AD223498-7A02-489E-84D6-4CE989CA9E5E @default.
- Q37471694 P31 Q37471694-2B55E09C-27D9-4732-8B25-D9FC94B750B6 @default.
- Q37471694 P356 Q37471694-A4D55678-CE8D-420E-BCEB-8B78303A1423 @default.
- Q37471694 P433 Q37471694-B08E2B65-042C-4DDF-BC18-4222A0E66EA9 @default.
- Q37471694 P4510 Q37471694-BC3928BA-DAB7-4753-8C82-7D048787DCE0 @default.
- Q37471694 P478 Q37471694-E15A5E6A-906D-4806-8317-97D5356275E6 @default.
- Q37471694 P50 Q37471694-76517FB5-F0E8-4F66-A507-3C09920E61BB @default.
- Q37471694 P50 Q37471694-ED2EC945-7DFC-4A88-B122-3B3DB3CA87E5 @default.
- Q37471694 P577 Q37471694-E2835E4F-6AB9-4FC4-A388-3AF50356F890 @default.
- Q37471694 P5875 Q37471694-AE24C6B2-8998-412F-84A6-4EE7C27E711B @default.
- Q37471694 P6216 Q37471694-a158e8f5-26de-4111-b744-cde77ae5a6c3 @default.
- Q37471694 P698 Q37471694-A049837F-8CD8-4DE7-BEC2-F534E42B8256 @default.
- Q37471694 P8608 Q37471694-E3D34FA3-7174-47E8-9BBD-4AC4CC58A723 @default.
- Q37471694 P921 Q37471694-312DF19F-4115-427C-A801-B78F9EF9EE0D @default.
- Q37471694 P932 Q37471694-8D13CD12-B179-47CF-9819-AA40AE4CCB68 @default.
- Q37471694 P356 S11060-013-1316-Y @default.
- Q37471694 P698 24352766 @default.
- Q37471694 P1433 Q15752119 @default.
- Q37471694 P1476 "Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry" @default.
- Q37471694 P2093 "A Barnadas" @default.
- Q37471694 P2093 "A Berrocal" @default.
- Q37471694 P2093 "A Colomer" @default.
- Q37471694 P2093 "M Benavides" @default.
- Q37471694 P2093 "M Cuatrecasas" @default.
- Q37471694 P2093 "M Gil" @default.
- Q37471694 P2093 "M J Quintana" @default.
- Q37471694 P2093 "N Erill" @default.
- Q37471694 P2093 "Oscar Gallego" @default.
- Q37471694 P2093 "P Murata" @default.
- Q37471694 P2093 "P P Segura" @default.
- Q37471694 P2507 Q46716597 @default.
- Q37471694 P275 Q19125117 @default.
- Q37471694 P2860 Q27824850 @default.
- Q37471694 P2860 Q27860948 @default.
- Q37471694 P2860 Q28300185 @default.
- Q37471694 P2860 Q33286242 @default.
- Q37471694 P2860 Q33346827 @default.
- Q37471694 P2860 Q33407127 @default.